CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.6050
+0.0050 (0.83%)
Aug 21, 2026, 4:08 PM HKT

HKG:0775 Cash Flow Statement

Millions HKD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-64.7-186.81-126.5517.25131.96162.8
Depreciation & Amortization
288.26245.32245.16233.74230.91246.88
Loss (Gain) From Sale of Assets
-693.46-693.46-244.83-94.63-51.510.76
Asset Writedown & Restructuring Costs
401.51401.51136.91-39.37-43.72-61.13
Loss (Gain) From Sale of Investments
-0.66-0.66-5.40.35-0.521.05
Loss (Gain) on Equity Investments
-0.36-0.36-0.15-0.33-0.02-1.21
Provision & Write-off of Bad Debts
0.50.55.480.6820.412.92
Other Operating Activities
207.01416375.35326.92197.27213.09
Change in Accounts Receivable
-31.88-31.88-86.951.43-189.54-117.36
Change in Inventory
-126.4-126.4-50.8354.6-95.5916.24
Change in Accounts Payable
163.19163.19105.28-36.46164.01-40.47
Operating Cash Flow
143.01186.95353.53514.18363.66423.58
Operating Cash Flow Growth
-29.23%-47.12%-31.24%41.39%-14.14%-20.22%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-244.98-244.98-196.53-287.68-216.02-216.2
Sale of Property, Plant & Equipment
101.89101.8980.8733.2124.661.14
Cash Acquisitions
62.2162.21----
Divestitures
-28.37-28.37----
Sale (Purchase) of Intangibles
2.352.35194.42126.3826.94-1.05
Sale (Purchase) of Real Estate
-53.08-53.08-60.6546.94179.48-44.79
Investment in Securities
-180.94-180.94---42.9-
Other Investing Activities
-69.4817.8213.9513.195.723.01
Investing Cash Flow
-433.8-346.5-96.65-67.96-22.12-257.88

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-2,1101,3663,1881,2241,150
Long-Term Debt Repaid
--1,654-1,372-3,268-1,480-1,176
Net Debt Issued (Repaid)
456.46456.46-6.5-80.17-256.23-25.87
Common Dividends Paid
----76.89-96.11-96.11
Other Financing Activities
-429.64-263.78-335.47-320.89-163-98.1
Financing Cash Flow
26.82192.68-341.98-477.95-515.34-220.08

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
8.5215.97-25.264.12-25.07-13.81
Net Cash Flow
-255.4549.1-110.35-27.61-198.87-68.2

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-101.98-58.03157.01226.51147.64207.37
Free Cash Flow Growth
---30.68%53.41%-28.80%6.06%
Free Cash Flow Margin
-1.85%-1.07%2.84%4.25%2.80%3.84%
Free Cash Flow Per Share
-0.01-0.010.020.020.010.02
Levered Free Cash Flow
-377.95-199.5687.5257.6190.23109.78
Unlevered Free Cash Flow
-219.15-32.75298.26259.13192.17170.92

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
265.43265.43335.47320.8916398.1
Cash Income Tax Paid
98.9298.9217.2266.7348.2218.42
Change in Working Capital
4.914.91-32.4469.57-121.12-141.59